CAPTRUST Financial Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,034
Closed -$530K 2314
2023
Q4
$530K Buy
16,034
+3,214
+25% +$90.9K ﹤0.01% 1700
2023
Q3
$349K Buy
+12,820
New +$356K ﹤0.01% 1900
2022
Q3
Sell
-1,758
Closed -$54K 2679
2022
Q2
$54K Buy
1,758
+1,262
+254% +$36.8K ﹤0.01% 2684
2022
Q1
$16K Sell
496
-452
-48% -$11.8K ﹤0.01% 3525
2021
Q4
$26K Sell
948
-16
-2% -$459 ﹤0.01% 3113
2021
Q3
$30K Buy
964
+17
+2% +$408 ﹤0.01% 2899
2021
Q2
$20K Sell
947
-2,560
-73% -$51.3K ﹤0.01% 3110
2021
Q1
$71K Buy
3,507
+366
+12% +$6.96K ﹤0.01% 2187
2020
Q4
$50K Sell
3,141
-62
-2% -$819 ﹤0.01% 1828
2020
Q3
$40K Buy
3,203
+3,103
+3,103% +$36.5K ﹤0.01% 1712
2020
Q2
$1K Buy
+100
New +$670 ﹤0.01% 2698
2019
Q4
Sell
-1,912
Closed -$14K 1246
2019
Q3
$14K Sell
1,912
-21
-1% -$151 ﹤0.01% 1398
2019
Q2
$15K Hold
1,933
﹤0.01% 1370
2019
Q1
$24K Sell
1,933
-123
-6% -$1.95K ﹤0.01% 1115
2018
Q4
$41K Buy
2,056
+318
+18% +$7.36K ﹤0.01% 834
2018
Q3
$49K Buy
1,738
+100
+6% +$2.38K ﹤0.01% 776
2018
Q2
$34K Buy
1,638
+761
+87% +$14.4K ﹤0.01% 776
2018
Q1
$12K Buy
877
+630
+255% +$9.02K ﹤0.01% 978
2017
Q4
$3K Buy
+247
New +$3.48K ﹤0.01% 1160

Other funds holding EVH

CAPTRUST Financial Advisors's EVH Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Evolent Health (EVH) in Q1 2024, closing a stake of 16,034 shares — an estimated $530K sold.

CAPTRUST Financial Advisors first reported a position in EVH in Q4 2017 and held it in 19 quarters. The position peaked at $530K in Q4 2023. 251 funds tracked by Wall St. Rank hold EVH as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Evolent Health position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 16,034 Evolent Health shares in Q1 2024, an estimated $530K.
  • CAPTRUST Financial Advisors first reported a position in Evolent Health in Q4 2017 and held it in 19 quarters.
  • CAPTRUST Financial Advisors's Evolent Health position peaked at $530K in Q4 2023.
  • 251 funds tracked by Wall St. Rank held Evolent Health as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.